Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell DexCom, Inc. (DXCM) – DexCom, Inc. Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

DexCom (DXCM) trades at $61.35, up 3.02% with strong fundamental performance including consistent earnings beats and robust revenue growth. The company reported Q1 2026 EPS of $0.56, beating expectations by 19%, with revenue reaching $1.19 billion, up 15% year-over-year. Technical indicators show bearish momentum with the stock trading near key resistance at $62, while fundamentals remain solid with 19.31% net income margin and 35.62% ROE. Analyst consensus remains strongly bullish with an $83.25 price target representing 36% upside potential.
DexCom presents a compelling growth story with expanding CGM market share and international expansion driving revenue growth. The primary investment opportunity lies in the company's dominant position in continuous glucose monitoring and strong execution. Key risks include competitive pressures from Abbott Laboratories, pricing pressure in the CGM market, and the stock's premium valuation at 25.56 P/E ratio. Near-term catalysts include Q2 2026 earnings and continued G7 product adoption.
Read full analysis

Key Stats

  • Market Cap
    $23.67B
  • Sector
    Health
  • 3M Drawdown
    -22.61%
  • Enterprise Value
    $22.64B
  • Dividend Yield
    -
  • Typical Hold Time
    60 days
$59.55
52W Low: $54.84
10 Nov 2025
52W High: $89.53
28 Jul 2025

DexCom, Inc. (DXCM) is currently valued at a market capitalization of $23.67B, with an enterprise value of $22.64B. Over the past 52 weeks, DexCom, Inc. has traded between a low of $54.84 and a high of $89.53, highlighting its annual price range. Over the past three months, DexCom, Inc. has recorded a drawdown of -22.61%, reflecting recent price volatility. On average, investors hold DexCom, Inc. for approximately 60 days, indicating typical investor behavior on the platform.

About DexCom, Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.


Technical Indicators
|
|
|
Overall Summary
Bearish (13)Neutral (6)Bullish (8)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $23.67B
  • Sector
    Health
  • 3M Drawdown
    -22.61%
  • Enterprise Value
    $22.64B
  • Dividend Yield
    -
  • Typical Hold Time
    60 days
$59.55
52W Low: $54.84
10 Nov 2025
52W High: $89.53
28 Jul 2025

DexCom, Inc. (DXCM) is currently valued at a market capitalization of $23.67B, with an enterprise value of $22.64B. Over the past 52 weeks, DexCom, Inc. has traded between a low of $54.84 and a high of $89.53, highlighting its annual price range. Over the past three months, DexCom, Inc. has recorded a drawdown of -22.61%, reflecting recent price volatility. On average, investors hold DexCom, Inc. for approximately 60 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!